Infliximab

ePAPER READ

DOWNLOAD ePAPER

susanrey

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

START NOW

Infliximab

• Recombinant monoclonal antibody to Human TNF. Infliximab (INN;

trade name Remicade) is a monoclonal antibody against tumour

necrosis factor alpha (TNF-α) used to treat autoimmune diseases.

• Infliximab was approved for the treatment of psoriasis, Crohn's

disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid

arthritis, and ulcerative colitis.

Cell Proliferation Assay with Immunoassay

Infliximab• Recombinant monoclonal antibody to Human TNF. Infliximab (INN;trade name Remicade) is a monoclonal antibody against tumournecrosis factor alpha (TNF-α) used to treat autoimmune diseases.• Infliximab was approved for the treatment of psoriasis, Crohn'sdisease, ankylosing spondylitis, psoriatic arthritis, rheumatoidarthritis, and ulcerative colitis.

Infliximab

Create successful ePaper yourself

Delete template?

Save as template?